Phillips T, Wang M, Robak T, Gallinson D, et al. Safety and efficacy of acalabrutinib plus bendamustine and rituximab in patients with treatment-naive or relapsed / refractory mantle cell lymphoma: phase Ib trial. Haematologica 2024 Sep 5. doi: 10.3324/haematol.2023.284896.
PMID: 39234862